Refine by
Pathology Data Software
5 software items found
by:Deep Lens Inc. based inColumbus, OHIO (USA)
Utilizing artificial intelligence, VIPER identifies and matches patients to precision trials in the narrow window of opportunity through lab-agnostic genomic data ingestion, EMR and pathology data in a way that is customized to both the patient and to the research. ...
by:Xybion Corporation based inPrinceton, NEW JERSEY (USA)
Intelligent Digital Pathology Solution: Xybion is dedicated to the advancement of software solutions for preclinical and toxicologic pathology. Our Digital Pathology software greatly increases productivity and lab throughput while allowing pathologists to streamline their workflows and review slides more efficiently. Our Digital Pathology software provides unique competitive and productivity ...
by:Flagship Biosciences Inc. based inBroomfield, COLORADO (USA)
Your next pathology-based CDx starts here. With the complexity of therapies increasing, the need for a robust companion diagnostic (CDx) has never been higher. Advances in tissue analysis technologies now require a more quantitative, accurate, and precise pathology-based CDx. Bringing your CDx to market requires a solid strategy to meet strict regulatory standards and critical timelines. Your CDx ...
by:Paige AI, Inc. based inNew York City, NEW YORK (USA)
By combining leading technology with groundbreaking AI, Paige derives novel insights from images of routine hematoxylin and eosin (H&E) stained tissue to identify morphologic features and biomarkers with clinical utility. Using proprietary computational pathology with exclusive clinical data cohorts, Paige rapidly uncovers and validates phenotypic patterns ...
by:nference, Inc. based inCambridge, MASSACHUSETTS (USA)
Our scientists use the nference platform and data in collaboration with your teams to tackle your most important questions and challenges. nference is creating the largest labeled EMR dataset in healthcare. EMR data contains longitudinal real-world, “deep data” rich in clinical phenotypes and outcomes spanning across therapeutic areas, but exists in in largely semi-structured and ...